Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:Results of the dose-escalation stage in patients with treatment-nave advanced renal cell carcinoma

Neeraj Agarwal Huntsman Cancer Center discusses Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:Results of the dose-escalation stage in patients with treatment-nave adv... Author: kidneycancer Added: 11/06/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts